BRD4 and non-small cell lung carcinoma: Although recent elucidation of the diagnostic, prognostic and therapeutic value of BRD4 in lots of cancers, such as breast cancer, acute myeloid leukemia, and colorectal cancer [20–22], its role in non-small cell lung cancer (NSCLC) remains elusive.